0001415889-22-007599.txt : 20220708 0001415889-22-007599.hdr.sgml : 20220708 20220708171852 ACCESSION NUMBER: 0001415889-22-007599 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220706 FILED AS OF DATE: 20220708 DATE AS OF CHANGE: 20220708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 221075302 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4-07082022_020741.xml X0306 4 2022-07-06 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2022-07-06 4 M 0 50000 108.49 A 248338 D Common Stock 2022-07-06 4 F 0 30935 362.78 D 217403 D Common Stock 100 I By Step-Son Common Stock 100 I By Step-Daughter Stock Option (right to buy) 108.49 2022-07-06 4 M 0 50000 0 D 2022-08-07 Common Stock 50000 45346 D Stock Options (right to buy) 106.59 2023-08-18 Common Stock 256010 256010 D Stock Options (right to buy) 125.05 2024-08-09 Common Stock 194771 194771 D Stock Options (right to buy) 177.32 2025-08-08 Common Stock 90334 90334 D Stock Options (right to buy) 177.32 2025-08-08 Common Stock 60222 60222 D Restricted Stock Units Common Stock 16937 16937 D Stock Options (right to buy) 190.41 2026-08-07 Common Stock 85725 85725 D Stock Options (right to buy) 190.41 2026-08-07 Common Stock 57150 57150 D Restricted Stock Units Common Stock 12879 12879 D Stock Options (right to buy) 267.87 2027-08-05 Common Stock 57442 57442 D Stock Options (right to buy) 267.87 2027-08-05 Common Stock 38295 38295 D Stock Options (right to buy) 267.87 2027-08-05 Common Stock 16650 16650 D Stock Options (right to buy) 267.87 2027-08-05 Common Stock 16650 16650 D Restricted Stock Units Common Stock 8016 8016 D Stock Options (right to buy) 481.82 2028-08-06 Common Stock 31315 31315 D Stock Options (right to buy) 481.82 2028-08-06 Common Sstock 20876 20876 D Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024. Fully exercisable. Options to purchase 15,056 shares vests on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vests on each of 8/8/2021 and 8/8/2022. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 6/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later ate as performance is certified by the Administrator). Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. /s/ Brenda S. Furlow, Attorney-in-Fact 2022-06-09